Zumatek is a breast imaging company specializing in the development of leading edge 3D dedicated imaging technologies for enhanced lesion detection.
Researchers at Duke University Medical Center founded ZumaTek for the purpose of commercializing a platform of innovative, patient friendly dedicated breast scanners designed to detect the presence of breast cancer much earlier than current technologies on the market. With the patient lying comfortably in the prone position, the scanners identify tumors in a patient's uncompressed breast by using either (a) nuclear medicine - to detect chemical changes in breast cells that are associated with malignancy; (b) low dose x-rays to collect CT images of the breast and provide a road-map pinpointing the suspected malignancy in 3D; or (c) a combination of both technologies in a dual modality scan providing both functional and structural imaging simultaneously. The device has undergone extensive proof of concept testing and advanced prototypes are available.